Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

57.18%

64.90%

58.42%

66.15%

Annual Dental Visits (ADV) Total

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

40.49%

46.74%

34.91%

48.16%

Appropriate Testing for Pharyngitis (CWP)

74.29%

77.56%

78.29%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

86.17%

93.08%

85.47%

91.27%

Asthma Medication Ratio (AMR) Total

59.88%

69.41%

64.96%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

63.91%

66.19%

63.72%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

54.74%

68.61%

60.83%

71.78%

Breast Cancer Screening (BCS)

49.11%

55.25%

Breast Cancer Screening (BCS-E)

48.68%

54.94%

50.68%

56.66%

Cervical Cancer Screening (CCS)

48.22%

59.85%

46.96%

60.10%

Childhood Immunization Status (CIS) Combination #10

24.57%

35.04%

18.89%

31.32%

Chlamydia Screening in Women (CHL) Total

51.14%

61.07%

53.40%

61.46%

Controlling High Blood Pressure (CBP)

51.82%

65.45%

52.07%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

80.56%

80.86%

81.63%

83.51%

Eye Exam for Patients With Diabetes (EED)

52.55%

56.20%

53.77%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

18.66%

27.73%

18.05%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

30.35%

46.35%

29.80%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

37.08%

41.03%

34.12%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

23.11%

37.31%

24.93%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

65.56%

57.90%

61.26%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

61.26%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

50.61%

55.72%

55.23%

59.64%

Immunizations for Adolescents (IMA) Combination #2

39.17%

38.93%

39.23%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

9.68%

16.94%

8.10%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

29.16%

38.80%

31.82%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

33.41%

39.01%

34.62%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

34.62%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

41.11%

31.93%

39.04%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

69.94%

75.79%

69.07%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

86.42%

86.96%

82.19%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

101.53%

≤ 92.72

99.85%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

81.51%

86.86%

79.02%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

70.32%

80.78%

71.26%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

10.61%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

10.61%

25.81%

10.98%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

6.03%

≤ 2.45%

6.78%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

81.03%

81.64%

79.33%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

58.18%

73.63%

59.95%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

71.08%

67.07%

71.51%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

57.52%

70.37%

57.40%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

47.79%

63.89%

46.69%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

70.93%

75.44%

68.00%

72.74%

Use of Opioids at High Dosage (HDO)

0.65%

≤ 2.19%

0.55%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

1.06%

≤ 0.87%

1.15%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

77.37%

83.21%

81.07%

86.20%